Financial Performance - Alta Equipment reported a quarterly loss of $0.65 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.60, and compared to a loss of $0.38 per share a year ago, indicating a decline in performance [1] - The company posted revenues of $423 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 3.11%, and down from $441.6 million in the same quarter last year [2] - Over the last four quarters, Alta Equipment has not surpassed consensus EPS estimates and has topped consensus revenue estimates only once [2] Stock Performance - Since the beginning of the year, Alta Equipment shares have lost approximately 27.1%, significantly underperforming the S&P 500, which declined by 4.7% [3] - The current Zacks Rank for Alta Equipment is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.30 on revenues of $482.42 million, and for the current fiscal year, it is -$1.39 on revenues of $1.89 billion [7] - The trend of estimate revisions for Alta Equipment is mixed, and future changes in estimates will be closely monitored following the recent earnings report [6][7] Industry Context - The Manufacturing - General Industrial industry, to which Alta Equipment belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, suggesting a challenging environment for the sector [8]

Financial Performance - Ingersoll Rand reported quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.73 per share, and down from $0.78 per share a year ago, representing an earnings surprise of -1.37% [1] - The company posted revenues of $1.72 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1%, compared to year-ago revenues of $1.67 billion [2] - Over the last four quarters, Ingersoll has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Stock Performance - Ingersoll shares have declined approximately 16.6% since the beginning of the year, while the S&P 500 has decreased by -5.3% [3] - The current Zacks Rank for Ingersoll is 4 (Sell), indicating expected underperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $0.84 on revenues of $1.87 billion, and for the current fiscal year, it is $3.36 on revenues of $7.47 billion [7] - The estimate revisions trend for Ingersoll is currently unfavorable, which may change following the recent earnings report [6] - The outlook for the Manufacturing - General Industrial industry, where Ingersoll operates, is in the bottom 41% of Zacks industries, which could materially impact stock performance [8]

Financial Data and Key Metrics Changes - Order bookings for Q3 were $883 million, up 32% compared to Q3 last year, marking the second highest bookings quarter in company history [6][25] - Q3 revenues were $652 million, down 13% from Q3 last year, primarily due to lower EV revenues as expected [6][27] - Adjusted earnings from operations in Q3 were $66 million, reflecting a decrease of 35% from the prior year [28] - The order backlog at the end of the quarter was approximately $2.1 billion, with a trailing 12-month book-to-bill ratio of 1.18 to 1 [7][30] Business Line Data and Key Metrics Changes - In life sciences, order backlog reached a record $1.2 billion, an increase of 39% compared to Q3 last year [11] - The food and beverage segment ended the quarter with a record backlog of $252 million, an increase of 22% compared to last year [12] - The energy segment showed strong funnel growth, supported by refurbishment opportunities for nuclear power generation facilities [13] - Transportation business continued restructuring to align with lower market demand, particularly in EV [15] Market Data and Key Metrics Changes - The life sciences market saw strong bookings in key sub-markets such as radiopharma and medical devices [11] - The energy market is experiencing growth, particularly in nuclear refurbishment and new builds [13][49] - The consumer products market remains stable with niche opportunities in automated warehouse solutions [14] Company Strategy and Development Direction - The company is focused on expanding market reach through high-value applications and growing recurring revenues to offset variability in bookings [8] - Integration activities for recent acquisitions are underway, with a strong M&A funnel being cultivated [19][21] - The company is committed to innovation, particularly in AI-driven initiatives, to enhance capabilities and deliver long-term value [22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating potential tariff impacts and emphasized the strength of their teams and processes [9][33] - The company anticipates continued margin improvement, albeit modestly in Q4, as restructuring efforts take effect [45][46] - Management remains optimistic about the strong order backlog and diversified bookings across markets, providing good revenue visibility [38][39] Other Important Information - The company generated cash flows from operating activities of $66.7 million in Q3 [34] - The net debt to adjusted EBITDA ratio was 3.7 times, with a commitment to reduce leverage to a target range of two to three times [37][114] - The company released its fifth annual Sustainability Report, reaffirming commitments to sustainability goals [23] Q&A Session Summary Question: Will margin improvements impact overall operating margins for fiscal Q4? - Management expects continued margin improvement, but it will be modest due to the timing of new business ramp-up in transportation [44][46] Question: Can you provide context on the energy or nuclear segment's growth? - The segment saw strong bookings from multiple customers, with ongoing opportunities in refurbishment and new builds [49][53] Question: What is the status of the dispute with the large EV customer? - The equipment has been delivered and remains in production at the customer site, with no revenues related to the dispute in the quarter [56][142] Question: How is the company addressing potential tariff impacts? - Management is closely monitoring the situation and working with customers and suppliers to mitigate challenges [33][62] Question: What is the outlook for capital allocation and leverage reduction? - The priority is to reduce leverage to the target range of two to three times, with ongoing cultivation of M&A opportunities [114][116] Question: How does the company view the nuclear market's potential? - Management sees a strong niche position in nuclear and anticipates it will be a valuable part of the revenue mix moving forward [118][120]

Financial Performance - Q3 2025 revenues decreased by approximately 133% year-over-year to $652 million [10], compared to $752 million in Q3 2024 [12] - Adjusted earnings from operations for Q3 2025 were $657 million [10], a decrease of approximately 351% compared to $1012 million in Q3 2024 [12] - Net income for Q3 2025 was $65 million [12], a significant decrease of approximately 862% compared to $472 million in Q3 2024 [12] - Organic revenue decreased by approximately 202% for Q3 and 188% year-to-date [12] Order Bookings and Backlog - Q3 2025 order bookings increased by approximately 32% year-over-year to $883 million [10] - The company's order backlog stands at $2060 million [10], providing good revenue visibility [11] - The trailing twelve-month book-to-bill ratio is 118, or 124 excluding transportation [10] Outlook - The company estimates Q4 F25 revenue to be in the range of $650 million to $710 million [13, 15] - The company has a strong and diversified order backlog across various sectors, including Life Sciences ($1220 million), Food and Beverage ($252 million), Energy ($158 million), Consumer Products ($180 million), and Transportation ($250 million) [11]

Financial Performance - Total revenues for the three months ended December 29, 2024, were $651,993, a decrease of 13.3% compared to $752,052 for the same period in 2023[3] - Net income for the three months ended December 29, 2024, was $6,505, down 86.2% from $47,182 in the same period last year[3] - Earnings per share attributable to shareholders for the three months ended December 29, 2024, were $0.07, compared to $0.48 for the same period in 2023[3] - Comprehensive income for the three months ended December 29, 2024, was $65,008, compared to $45,049 for the same period in 2023, an increase of 44.4%[5] - The company reported an income before income taxes of $10,642 for the three months ended December 29, 2024, compared to $60,994 for the same period in 2023[70] Assets and Liabilities - Total assets increased to $4,666,313 as of December 29, 2024, up from $4,088,799 as of March 31, 2024, representing a growth of 14.1%[2] - Total liabilities increased to $2,910,273 as of December 29, 2024, from $2,404,852 as of March 31, 2024, reflecting a rise of 21%[2] - Cash and cash equivalents rose to $263,152 as of December 29, 2024, compared to $170,177 as of March 31, 2024, an increase of 54.6%[2] - Trade receivables as of December 29, 2024, were $663,146,000, an increase of 51.7% from $437,329,000 as of March 31, 2024[91] - Contract assets decreased to $619,510,000 as of December 29, 2024, from $704,703,000 as of March 31, 2024[91] - Net contract balances increased to $853,614,000 as of December 29, 2024, compared to $778,772,000 as of March 31, 2024[91] Operating Costs and Expenses - The company reported operating costs of $454,061 for the three months ended December 29, 2024, down 15.7% from $538,435 in the same period last year[3] - The company incurred restructuring costs of $3,360 for the three months ended December 29, 2024, compared to $16,228 in the same period last year[3] - Interest expense for the three months ended December 29, 2024, was $25,255,000, an increase of 49.5% from $16,898,000 in 2023[94] - The company recorded risk management losses of $13,310 for the three months ended December 29, 2024, compared to gains of $1,487 in the same period of the previous year[49] Equity and Shareholder Information - Total equity as of December 31, 2023, reached CAD 1,618,266 thousand, up from CAD 1,130,583 thousand as of March 31, 2023, indicating a growth of approximately 43%[7] - The Company has a normal course issuer bid allowing for the repurchase of up to 8,259,180 common shares until December 15, 2025[65] - As of December 29, 2024, the Company has repurchased 1,020,887 common shares for $44,983 under the previous NCIB program[66] - The weighted average number of common shares outstanding for the three months ended December 29, 2024, was 97,926,990, a decrease from 98,906,456 in 2023[97] Acquisitions - The acquisition of Paxiom Group was completed for a total purchase price of CAD 146,438 thousand, enhancing the company's capabilities in packaging solutions[22] - The total purchase price for the acquisition of Paxiom was $146,438, with a net identifiable asset value of $66,901 and residual goodwill of $79,537[24] - Paxiom contributed approximately $22,323 in revenue and incurred a net loss of $1,235 from the acquisition date to December 29, 2024[26][27] - The total purchase price for the acquisition of Heidolph was $45,064, with net identifiable assets valued at $42,722 and residual goodwill of $2,342[28][29] - Heidolph contributed approximately $23,335 in revenue and incurred a net loss of $1,066 from the acquisition date to December 29, 2024[31] Cash Flow and Financing - Cash flows provided by operating activities for the nine months ended December 31, 2023, were CAD 11,205 thousand, a significant decrease from CAD 110,508 thousand in the previous year[9] - The company recorded a significant cash outflow of CAD 269,274 thousand in investing activities for the nine months ended December 31, 2023, compared to CAD 315,454 thousand in the previous year[9] - The Company issued $600,000 in CAD Senior Notes at an interest rate of 6.50% per annum, with the latest issuance completed on December 19, 2024[61] - The Company has a total of $1,611,232 in long-term debt as of December 29, 2024, which includes $519,335 from the Credit Facility and $1,103,380 from Senior Notes[64] Taxation - The effective income tax rate increased to 29% for the nine months ended December 29, 2024, compared to 24% for the same period in 2023[70] - The company recognized income tax expense related to Pillar Two income taxes of CAD 1,579 for the nine months ended December 29, 2024, compared to CAD 0 in the same period of 2023[71] Stock Options and Compensation - The number of stock options outstanding increased to 1,035,380 with a weighted average exercise price of CAD 36.05 as of December 29, 2024, compared to 865,386 options at CAD 33.43 in the prior year[74] - The company granted 241,327 time-vesting stock options during the nine months ended December 29, 2024, compared to 176,112 in the same period of 2023[73] - The company incurred stock-based compensation expenses of CAD 9,907 thousand for the nine months ended December 31, 2023, compared to CAD 8,146 thousand in the previous year[9] Market Conditions and Risks - The company expects to continue monitoring the potential impact of tariffs on its financial condition and operations, which remains uncertain[21] - The company recorded unrealized losses of $5,016 on foreign currency risk management forward contracts during the three months ended December 29, 2024[49]

Q2 2025 Earnings Call November 6, 2024 8:30am ET Today's Hosts /ATS" Andrew Hider Ryan McLeod Chief Executive Officer Chief Financial Officer Forward Looking Statements Note to Reader: This presentation and the oral statements made during this call contain certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws ("forward-looking statements"). All such statements are made pursuant to the "saf ...

ATS Corporation. (NYSE:ATS) Q2 2025 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants David Galison - Head of Investor Relations Andrew Hider - Chief Executive Officer Ryan McLeod - Chief Financial Officer Conference Call Participants Sabahat Khan - RBC Justin Keywood - Stifel David Ocampo - Cormark Securities Patrick Sullivan - TD Cowen Maxim Sytchev - National Bank Financial Michael Glen - Raymond James Patrick Baumann - JPMorgan Operator Welcome to the ATS Corporation Second Quart ...

Financial Performance - For the six months ended September 29, 2024, the company reported an income (loss) before income taxes of $(1,366) thousand, compared to $67,561 thousand for the same period last year[93]. - For the six months ended September 29, 2024, total company revenue was CAD 1,307,051, a decrease from CAD 1,489,365 for the same period in 2023, representing a decline of approximately 12.2%[119]. - The total company revenue for the three months ended September 29, 2024, was CAD 612,781, down from CAD 735,716 for the same period in 2023, reflecting a decline of approximately 16.7%[119]. - Revenue from construction contracts for the three months ended September 29, 2024, was CAD 317,462, compared to CAD 479,755 for the same period in 2023, indicating a decrease of about 33.9%[119]. - The company reported total revenue from external customers in the United States for the six months ended September 29, 2024, at CAD 583,063, compared to CAD 723,755 for the same period in 2023, a decrease of approximately 19.4%[118]. Debt and Financing - As of September 29, 2024, the Company had utilized $732,532 under its Credit Facility, with $732,520 classified as long-term debt[73]. - The Company has additional credit facilities available totaling $110,935, with $19,497 outstanding as of September 29, 2024[78]. - The Company's U.S. $350,000 aggregate principal amount of senior notes bears interest at a rate of 4.125% per annum and matures on December 15, 2028[79]. - On August 21, 2024, the Company completed a private placement of $400,000 aggregate principal amount of senior unsecured notes, bearing interest at a rate of 6.50% per annum, maturing on August 21, 2032[82]. - The Company’s long-term debt as of September 29, 2024, is $1,594,002, up from $1,171,796 on March 31, 2024[85]. - The Company met all financial covenants under its Credit Facility as of September 29, 2024[77]. Restructuring and Cost Management - The North American Electric Vehicle market is experiencing a slowdown in sales growth, leading to reduced investment and program cancellations, prompting the Company to initiate cost structure reductions in its transportation-related businesses, with restructuring expenses of $17,075 recorded in Q2 fiscal 2025[71]. - The total estimated cost of restructuring activities is expected to be at the higher end of the previously disclosed range of $15,000 to $20,000[71]. Stock and Shareholder Activity - During the six months ended September 29, 2024, the Company repurchased 1,020,887 common shares under its normal course issuer bid for $44,983[89]. - The balance of common shares outstanding decreased from 98,219,496 on March 31, 2024, to 96,869,371 on September 29, 2024[90]. - The total number of stock options outstanding increased to 1,048,581 with a weighted average exercise price of $36.16 as of September 29, 2024, compared to 906,218 options at $32.83 as of October 1, 2023[98]. - The company granted 241,327 time-vesting stock options during the six months ended September 29, 2024, with a weighted average exercise price of $45.37[100]. - The stock-based compensation expense for the six months ended September 29, 2024, totaled $6,423 thousand, down from $13,445 thousand for the same period last year[108]. Tax and Deferred Tax - The company recognized an income tax expense related to Pillar Two income taxes of $538 thousand for the three months ended September 29, 2024, and $1,051 thousand for the six months ended September 29, 2024[93]. - The company recognized a deferred tax recovery of $(10,882) thousand for the three months ended September 29, 2024, compared to a deferred tax expense of $9,683 thousand for the same period last year[93]. Contract and Asset Management - Total net contract assets and liabilities as of September 29, 2024, were CAD 344,802, compared to CAD 392,499 as of March 31, 2024, showing a decrease of approximately 12.2%[124]. - Estimated earnings for contracts in progress as of September 29, 2024, were CAD 1,484,945, compared to CAD 1,354,259 as of March 31, 2024, indicating an increase of about 9.6%[124]. - The weighted average number of common shares outstanding for the three months ended September 29, 2024, was 97,926,369, down from 98,883,583 for the same period in 2023[130]. Working Capital and Liabilities - Total change in non-cash working capital decreased by $74,280 in the three months ended September 29, 2024, compared to a decrease of $87,212 in the same period last year[134]. - Contract assets increased to $136,775 in the three months ended September 29, 2024, from $15,768 in the previous year[134]. - Accounts payable and accrued liabilities decreased to $72,030 in the latest quarter, compared to $5,031 in the same period last year[134]. - Contract liabilities increased to $120,509 in the three months ended September 29, 2024, from $35,770 in the previous year[134]. - Provisions increased to $8,700 in the latest quarter, compared to a decrease of $1,784 in the same period last year[134]. - Inventories decreased to $8,377 in the three months ended September 29, 2024, from $10,473 in the previous year[134]. - Foreign exchange and other liabilities increased to $7,999 in the latest quarter, compared to $1,397 in the same period last year[134]. - Income tax receivable slightly increased to $2,343 in the latest quarter, compared to $2,219 in the previous year[134]. - Deposits, prepaids, and other assets increased to $9,596 in the three months ended September 29, 2024, from a decrease of $4,297 in the previous year[134]. - Total accounts receivable decreased to $(17,972) in the latest quarter, compared to $(107,220) in the same period last year[134].

Financial Data and Key Metrics - Q1 2025 order bookings were $817 million, up 18% YoY, driven by organic growth in life sciences and consumer products [7] - Q1 revenues were $694 million, down 8% YoY, primarily due to lower transportation revenues [7] - Adjusted earnings from operations in Q1 were $86 million, down 16% YoY [7] - Gross margin, excluding acquisition-related inventory fair value charges, was 29.9%, up 168 basis points YoY [20] - Backlog at the end of Q1 was $1.9 billion, with a trailing 12-month book-to-bill ratio of 1.02:1 [18] Business Line Data and Key Metrics - Life sciences backlog reached $990 million, up 26% YoY, the highest in company history [7] - Food and beverage backlog was $216 million, up 15% YoY [8] - Transportation backlog was $417 million, with smaller opportunities in the sales funnel [10] - After-sales services saw the launch of a service experience center in Cambridge, enabling real-time asset monitoring [12] Market Data and Key Metrics - Life sciences opportunity funnel remains strong, with large orders in wearable devices, GLP-1 auto-injectors, and radioisotope production lines [7][8] - Energy market opportunities include CANDU reactor refurbishment, SMRs, and energy storage [9][31] - Transportation market faces challenges, with EV projects nearing completion and reduced investments by industry participants [10] Company Strategy and Industry Competition - The company is realigning its EV business and adjusting its cost structure due to market conditions [10] - The acquisition of Paxiom is expected to enhance market position and diversify offerings in food technologies and packaging [8] - The company is focused on expanding its international customer base and leveraging its expertise in energy storage [9][31] Management Commentary on Operating Environment and Future Outlook - Management remains confident in the strategic direction, particularly in regulated end markets like life sciences [17] - The company expects Q2 revenue conversion to be in the 33% to 36% range of order backlog, with challenges in transportation [21] - Long-term growth opportunities are seen in life sciences, energy, and digital offerings [9][13] Other Important Information - The company announced the acquisition of Heidolph Instruments, a leading manufacturer of lab equipment [15] - The company launched several new products, including AI-based heat exchanger and compressor monitoring systems [13] - The company is actively engaged in M&A activities, with a diversified portfolio of target sizes and markets [15] Q&A Session Summary Question: Working Capital Situation - The increase in working capital was primarily due to timing issues in life sciences and EV projects [27] - No risk of obsolescence in the equipment being built, as contracts are being fulfilled as expected [29] Question: Energy Market Opportunities - Opportunities include CANDU reactor refurbishment, SMRs, and energy storage [31][32][33] Question: GLP-1 Market Outlook - The GLP-1 market is in line with internal expectations, with strong support for auto-injector production [35] Question: Q2 Revenue and Margin Guidance - Q2 revenue is expected to be between $620 million and $680 million, with margin pressure due to lower revenues [37][38] Question: Restructuring Actions - The company is reallocating resources and reducing workforce to align with market activity, with expected savings exceeding costs [40] Question: Life Sciences Backlog - GLP-1 orders comprise roughly 20% of the life sciences backlog [45] Question: M&A and NCIB Strategy - The company views NCIB as opportunistic and prioritizes internal investment and M&A based on return on invested capital [51] Question: Tax Rate - The effective tax rate is expected to be in the 25% to 27% range for fiscal 2025 [64] Question: Revenue Outlook - The overall revenue outlook for 2025 remains unchanged, with strong bookings in life sciences and recent acquisitions offsetting transportation declines [67] Question: Gross Margin Improvement - Gross margin improvement was driven by acquisitions, mix benefits, and easing supply chain headwinds [69]

Financial Performance - Total revenues for the three months ended June 30, 2024, were $694,270, a decrease of 7.9% compared to $753,649 for the same period in 2023[5] - Net income for the same period was $35,327, down 26.0% from $47,724 in the prior year[5] - Earnings per share attributable to shareholders decreased to $0.36 from $0.50, reflecting a decline of 28.0%[5] - Comprehensive income for the three months ended June 30, 2024, was $46,028, compared to $33,167 in the same period last year, reflecting a growth of 38.6%[7] - Revenue from construction contracts was $394,993, down 22.4% from $508,868 in the prior year[75] - Life Sciences market revenue increased to $328,421, up 15.2% from $284,970 in the previous year[76] - The company reported net finance costs of $19,518 for the three months ended June 30, 2024, compared to $16,946 in the same period last year[79] Assets and Liabilities - Total assets increased to $4,242,282 as of June 30, 2024, compared to $4,088,799 as of March 31, 2024, representing a growth of 3.8%[3] - Total liabilities increased to $2,554,727, compared to $2,404,852, marking a rise of 6.2%[3] - Long-term debt rose to $1,289,758 from $1,171,796, an increase of 10.0%[3] - Trade receivables as of June 30, 2024, were $538,689, an increase from $437,329 as of March 31, 2024[76] - Contract assets rose to $726,427 from $704,703, while contract liabilities increased to $365,359 from $312,204[76] Cash Flow and Equity - Cash and cash equivalents rose to $185,086 from $170,177, an increase of 8.3%[3] - Cash flows used in operating activities for the three months ended July 2, 2023, were $(107,796), while cash flows provided by financing activities were $92,375[14] - The company reported total equity of $1,529,454 as of July 2, 2023, up from $1,130,583 as of March 31, 2023[11] - Cash and cash equivalents at the end of the period were $123,520, down from $159,867 at the beginning of the period[14] Shareholder Activities - The company repurchased 1,020,887 common shares for $44,983 during the three months ended June 30, 2024, with a total of 7,023,631 shares remaining available for repurchase under the NCIB program[49] - The authorized share capital consists of an unlimited number of common shares, and the company intends to purchase up to 8,044,818 common shares under the normal course issuer bid (NCIB) by December 14, 2024[48] - The total number of common shares outstanding decreased from 98,219,496 on March 31, 2024, to 97,200,364 on June 30, 2024, reflecting a repurchase of shares[50] - The weighted average number of common shares outstanding increased to 98,119,205 from 94,397,253 year-over-year[82] Expenses and Costs - The company recognized an income tax expense of $12,748 for the three months ended June 30, 2024, compared to $14,380 for the same period in the previous year[54] - The company recognized a tax expense related to Pillar Two income taxes of $513 during the three months ended June 30, 2024[54] - The company recognized an expense of $837 related to short-term and low-value leases in the cost of revenues for the three months ended June 30, 2024, down from $1,001 in the same period last year[31] - The company reported a total stock-based compensation expense of $3,723 for the three months ended June 30, 2024, down from $9,990 in the same period last year[67] Acquisitions and Future Plans - The company acquired Paxiom Group for cash consideration of $140,000, with the transaction closing on July 24, 2024[24] - The company expects to close the acquisition of Heidolph Instruments in the third calendar quarter of 2024, subject to closing conditions[25] - The company plans to reduce its cost structure in response to a slowdown in the North American EV market, with estimated costs of $15 million to $20 million expected to commence in the second quarter of fiscal 2025[38] Currency and Risk Management - The company reported a currency translation adjustment of $11,393, compared to a loss of $20,227 in the prior year[7] - The company recorded risk management losses of $1,310 on foreign currency risk management forward contracts for the three months ended June 30, 2024, compared to gains of $6,636 in the prior year[36] Working Capital - Total change in non-cash working capital was a decrease of $106,874 for the three months ended June 30, 2024, compared to a decrease of $184,454 in the prior year[84] - The company reported a change in non-cash operating working capital of $(184,454) for the three months ended July 2, 2023[14] - As of June 30, 2024, the total balance of right-of-use assets increased to $108,044, up from $105,661 as of March 31, 2024, reflecting an addition of $9,929 during the quarter[29] - Lease liabilities rose to $114,309 as of June 30, 2024, compared to $111,379 at the end of March 2024, with additions of $9,929 and interest of $1,420 recorded[30] Minimum Purchase Obligations - The minimum purchase obligations as of June 30, 2024, totaled $350,163, with $337,299 due within one year[68]